Skip to main content
Yantai Zhenghai Bio-Tech Co., Ltd. logo

Yantai Zhenghai Bio-Tech Co., Ltd. — Investor Relations & Filings

Ticker · 300653 ISIN · CNE100002NZ1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 970 across all filing types
Latest filing 2023-04-10 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300653

About Yantai Zhenghai Bio-Tech Co., Ltd.

https://www.zhbio.com

Yantai Zhenghai Bio-Tech Co., Ltd. specializes in the research, development, production, and sale of regenerative medicine materials. The company focuses on tissue engineering and biomaterials to provide solutions for clinical repair and functional reconstruction. Its core product portfolio includes the Heal-All oral repair membrane, absorbable hard cerebral (spinal) membrane patches, and skin repair membranes. These products are widely utilized in stomatology, neurosurgery, and orthopedics. The company leverages advanced processing technologies to ensure biocompatibility and safety in its medical devices. By integrating research with clinical needs, it develops innovative bone repair materials and other biological scaffolds designed to facilitate natural tissue regeneration.

Recent filings

Filing Released Lang Actions
独立董事关于相关事项的独立意见
Regulatory Filings Classification · 95% confidence The document is titled '独立董事关于相关事项的独立意见' which translates to 'Independent Directors' Opinions on Related Matters'. It contains independent directors' opinions on the 2022 profit distribution plan, internal control self-evaluation report, use of idle funds for cash management, accounting policy changes, and external guarantees and related party fund occupation. The document is dated April 2023 and signed by independent directors. It is a formal statement of independent directors' opinions on various corporate governance and financial matters, typically issued as part of regulatory compliance and corporate governance disclosures in Chinese listed companies. It is not a full annual report, audit report, or earnings release, but rather a specialized governance-related opinion document. This fits best under the category of Regulatory Filings (RNS), as it is a regulatory disclosure document that does not fit other specific categories like Annual Report or Audit Report. The document length is about 2123 characters, which is relatively short and focused on independent directors' opinions rather than full financial data or detailed reports.
2023-04-10 Chinese
关于使用闲置自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is titled as an announcement regarding the use of idle self-owned funds for cash management by the company. It details the board and supervisory committee approvals, investment purpose, amount, types of investment products, risk control measures, and impact on daily operations. The document is an announcement of a corporate financing or capital management activity rather than a financial report or earnings release. It does not contain financial statements or detailed financial results but rather informs shareholders and the market about the company's plan to use idle funds for cash management within a specified limit. This fits the definition of a Capital/Financing Update (CAP). The document length is 2716 characters, which is consistent with an announcement rather than a full report. Therefore, the appropriate classification is CAP with high confidence.
2023-04-10 Chinese
上市公司2022年非经营性资金占用及其他关联资金往来情况汇总表
Regulatory Filings Classification · 90% confidence The document is a summary table of non-operating fund occupation and other related party fund transactions for the year 2022, prepared by a company. It includes financial figures and relationships with controlling shareholders and related parties. The document is short (1004 characters) and appears to be a specific financial disclosure related to related party transactions rather than a full financial report. It does not contain comprehensive financial statements or detailed management discussion. It is not an announcement of a report but a specific financial disclosure. Given the nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2023-04-10 Chinese
2022年度独立董事述职报告（张兰丁）
Board/Management Information Classification · 95% confidence The document is titled '独立董事述职报告' which translates to 'Independent Director's Work Report' for the year 2022. It details the independent director's attendance at board meetings, opinions on company matters, committee work, investigations, and efforts to protect investor rights. It is a narrative report on the independent director's duties and activities rather than a financial report or regulatory filing. The document length is 2523 characters, which is relatively short but contains substantive content about the director's work rather than just an announcement. This type of document is typically classified under Board/Management Information (MANG) as it relates to management and board activities and disclosures about directors' roles and opinions.
2023-04-10 Chinese
2022年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as the "2022 年年度报告摘要" which translates to "2022 Annual Report Summary". It contains detailed financial data for the year 2022, including total assets, net profit, earnings per share, and quarterly financial data. It also discusses business operations, product registrations, market conditions, and company management strategies. The presence of audited financial statements and comprehensive business and financial information indicates this is a full annual report or a summary thereof. The document length is 7966 characters, which is substantial and contains substantive financial data, not just an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2022
2023-04-10 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is titled '会计政策变更公告' which translates to 'Announcement of Change in Accounting Policies'. It details the company's board and supervisory meetings approving changes in accounting policies based on new accounting standards issued by the Ministry of Finance. The document explicitly states that the changes have no impact on the financial statements and do not require shareholder approval. It is an announcement about a change in accounting policy rather than a full financial report or audit report. The document is relatively short (2081 characters) and serves as a formal disclosure of the policy change. This fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements that do not fit other specific categories like Annual Report, Audit Report, or Interim Report.
2023-04-10 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.